Anemia during pregnancy is defined as a serum hemoglobin of less than 10.5 g/dL in the second trimester of pregnancy, and it is defined as a serum hemoglobin of less than 11 g/dL in the third trimester of pregnancy. There is evidence that maternal anemia raises the likelihood of health issues occurring in both the mother and the child. The anemia known as megaloblastic anemia is characterized by macrocytosis as a consequence of the reduction of DNA synthesis while erythropoiesis is taking place. This results in an increased number of red blood cells. The presence of megaloblastic anemia is often identified by chance during the course of routine blood testing. The only persons who have symptoms of anemia during pregnancy are those who already have a severe level of anemia. If treatment for megaloblastic anemia is not received, the condition may lead to thrombocytopenia. The first step in diagnosing megaloblastic anemia is identifying the morphological (increased mean cellular volume) and laboratory (specific vitamin deficiency) symptoms of megaloblastosis. This will lead to the identification of megaloblastic anemia. We take a look at the situation of a woman in her thirties who is expecting a child but has been told she has significant megaloblastic anemia and thrombocytopenia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.